Device-Related Reoperations 8 Years Following Sacral Neuromodulation Implantation in Older Women.

Abstract

The objective was to describe long-term device-related reoperations at 8years following sacral neuromodulation (SNM) in women older than 65years for the indications of overactive bladder (OAB), fecal incontinence (FI), and/or idiopathic urinary retention (UR). The 2010-2019 Medicare 100% Outpatient Limited Dataset was used to identify women aged 65years and older who underwent SNM to treat OAB, FI, and/or UR. The primary study outcome was any device-related reoperation within 8years following initial implantable pulse generator (IPG) implantation defined as: IPG revision or removal; IPG replacement; or neuro-electrode revision or removal. Kaplan-Meier survival analysis was also performed to evaluate time to adverse event. The cohort included 32,454 women with a mean age of 74years. The most common indication for SNM was OAB (71%) followed by UI and FI (13%) and FI only (8%). Staged SNM procedures were performed more frequently (60%) than percutaneous nerve evaluation/full implants. The overall rate of device-related reoperations was 24% over 8years: 12% of patients underwent removal or revision of the neuro-electrode, 11% underwent removal or revision of the IPG, and 13% underwent replacement of the IPG. The mean follow-up was 3.9 ± 2.4years. The cumulative incidence of any device-related reoperations was 9.4% at 1year, 20% at 3years, and 43% at 8years. In the 8years following SNM implantation, the rate of device-related reoperation among female Medicare beneficiaries was 43%, and staged implants were associated with a 17% lower likelihood of undergoing any device-related reoperations.